PhoenixBio News

PhoenixBio: Announcements of individual stocks regarding the completion of payment for new shares as restricted stock compensation.

Jul 11 02:30 ET

PhoenixBio: Interim report

Jul 1 20:35 ET

PhoenixBio: Corporate Governance Report 07/01/2024

Jul 1 02:37 ET

PhoenixBio: Extraordinary Report

Jul 1 01:59 ET

PhoenixBio: Internal control report - The 23rd term (April 1, 2023 - March 31, 2024)

Jun 26 21:06 ET

PhoenixBio: Confirmatory letter.

Jun 26 21:04 ET

PhoenixBio: Financial Report - Term 23 (2023/04/01 - 2024/03/31)

Jun 26 21:03 ET

PhoenixBio: Announcement of changes in the representative director.

Jun 26 03:00 ET

PhoenixBio: Announcements of individual stocks regarding the issuance of new stocks with transfer restrictions as stock compensation

Jun 26 03:00 ET

PhoenixBio: Explanatory material about business plans and growth potential.

Jun 25 02:30 ET

PhoenixBio: Regarding matters related to dominant shareholders.

Jun 14 02:30 ET

PhoenixBio: Notice of Convening Regular Shareholders' Meeting for the Year 2024.

Jun 4 19:00 ET

PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.

May 15 02:30 ET

PHOENIXBIO: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (consolidated)

May 15 02:30 ET

PhoenixBio: About the conclusion of a business alliance agreement with Ecocell Co., Ltd.

Mar 15 02:00 ET

Phoenix Bio: Confirmation Letter

Feb 14 01:51 ET

Phoenix Bio: Quarterly Report - 23rd Quarter (2023/10/01 to 2023/12/31)

Feb 14 01:50 ET

PhoenixBio: Notice Concerning the Recording of Non-Operating Expenses (Foreign Exchange Losses)

Feb 14 01:30 ET

PhoenixBio: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Feb 14 01:30 ET

PhoenixBio: Notice of Japanese Patent Assessment for “Human Fatty Liver Model Cells for Use in Screening Methods”

Feb 9 02:00 ET